| Dictionary, Encyclopedia and Thesaurus - The Free Dictionary 1,507,737,980 visitors served. |
|
Dictionary/ thesaurus | Medical dictionary | Legal dictionary | Financial dictionary | Acronyms | Idioms | Encyclopedia | Wikipedia encyclopedia | ? |
danazol |
Also found in: Wikipedia | 0.04 sec. |
|
danazol /dan·a·zol/ (dah´nah-zōl) an anterior pituitary suppressant used in the treatment of endometriosis, fibrocystic breast disease, and gynecomastia and the prophylaxis of attacks of hereditary angioedema. danazol [dan′əzol] a synthetic androgen that acts to suppress the output of gonadotropins from the pituitary, suppress ovarian hormone production, and directly block ovarian hormone receptors. indications It is prescribed in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema when alternative hormonal therapy is ineffective, contraindicated, or intolerable. contraindications Genital bleeding; cardiac, liver, or kidney dysfunction; or known hypersensitivity to this drug prohibits its use. It is not prescribed during pregnancy or lactation. adverse effects Among the most serious adverse reactions are muscle spasms, nausea, weight gain, acne, edema, oily skin, voice changes, and other androgenic effects. danazol (dan´ n brand name: Danocrine; drug class: androgen, α-ethinyl testosterone derivative; action: decreases FSH and LH output; uses: endometriosis, prevention of hereditary angioedema, fibrocystic breast disease. danazol an attenuated androgen that suppresses the ovarian-pituitary axis by inhibiting the release of gonadotropins from the pituitary gland. In animals, it has been used in the treatment of immune-mediated disorders, including anemia and thrombocytopenia. danazol Cyclomen (CA) Pharmacologic class: Androgen (synthetic) Therapeutic class: Sex hormone Pregnancy risk category X FDA Boxed Warning• Drug is contraindicated during pregnancy. Patient must have negative pregnancy test immediately before therapy starts, and should use nonhormonal contraceptive method during therapy. ActionSuppresses pituitary-ovarian axis, probably through a combination of depressed hypothalamic-pituitary response to reduced estrogen production, altered sex hormone metabolism, and interaction with sex hormone receptors AvailabilityCapsules: 50 mg, 100 mg, 200 mg ⊘Indications and dosages ➣ Moderate endometriosis amenable to hormonal management Adults and adolescents: 400 mg P.O. b.i.d for up to 9 months. In milder cases, 100 to 200 mg P.O. b.i.d. initially, with dosage adjustments based on patient response. ➣ Fibrocystic breast disease Adults and adolescents: 100 to 200 mg P.O. b.i.d. for 2 to 6 months ➣ Hereditary angioedema Adults and adolescents: 200 mg P.O. two to three times daily. If possible, decrease dosage by 50% or less q 1 to 3 months. If acute angioedema attack occurs, increase dosage up to 200 mg/day. Off-label uses• Menorrhagia Contraindications• Hypersensitivity to drug PrecautionsUse cautiously in: Administration• Verify that patient isn't pregnant before initiating therapy. Start therapy during menstruation.
Adverse reactionsCNS: headache, tremor, emotional lability, irritability, nervousness, anxiety, depression, sleep disorders, epilepsy exacerbation, benign intracranial hypertension CV: increased blood pressure, palpitations, tachycardia, thrombotic events, myocardial infarction EENT: cataracts, blurred vision, nasal congestion, papilledema GI: nausea, vomiting, constipation, indigestion, gastroenteritis, anorexia, pancreatitis GU: hematuria; amenorrhea; menstrual cycle disturbances (spotting, altered cycle); anovulation; vaginal dryness; changes in breast size; clitoral enlargement; testicular atrophy; abnormalities in semen volume, viscosity, mobility, and sperm count; decreased libido Hematologic: reversible erythrocytosis, eosinophilia, polycythemia, thrombocytosis, leukocytosis, leukopenia, thrombocytopenia , splenic peliosis Hepatic: cholestatic jaundice, peliosis hepatitis, hepatic adenoma, malignant hepatic tumor Metabolic: increased insulin requirement (in diabetic patients) Musculoskeletal: muscle cramps, spasms, pain, or fasciculations; joint pain and swelling; joint "lock-up"; pain in back, neck, or limbs; carpal tunnel syndrome Skin: acne, hirsutism, oily skin, rash, photosensitivity, yellowing of skin and sclera, pigmentation changes, seborrhea, sweating Other: weight gain, edema, deepening of voice, Stevens-Johnson syndrome InteractionsDrug-drug. Carbamazepine: increased carbamazepine blood level Cyclosporine, tacrolimus: increased blood levels of these drugs, increased risk of nephrotoxicity Insulin, oral hypoglycemics: increased blood glucose level and insulin resistance, necessitating adjustment of insulin or oral hypoglycemic dosages Warfarin: prolonged prothrombin time Drug-diagnostic tests. Creatine kinase, glucagon, glucose, hepatic enzymes, low-density lipoproteins, plasma proteins, sex hormone-binding globulins: increased levels Glucose tolerance, thyroid function: altered test results High-density lipoproteins: decreased level Patient monitoring☞ Assess for early indications of benign intracranial hypertension, such as headache, nausea, vomiting, and visual disturbances. Screen for papilledema; if present, refer patient to neurologist immediately. Patient teaching• Advise female of childbearing age to use barrier contraception, because drug causes fetal abnormalities. danazol Endocrinology A non-virilizing anabolic androgen used to manage HANE, fibrocystic breast disease, endometriosis, and possibly autoimmune hemolytic anemia and autoimmune thrombocytopenia, but may mediate immune thrombocytopenia Adverse
effects Weight gain, edema, acne, hirsutism, deepening of voice, clitorimegaly, menometrorrhagia, ↓ HDL-C, ↑ liver enzymes, peliosis hepatis, benign intracranial HTN. See Hereditary angioneurotic edema. How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content. |
|
| ? Mentioned in | ? References in periodicals archive | |
|---|---|---|
Cytoplasmic and nuclear estrogen binding capacity in the rat uterus during treatment with danazol and testosterone. Comparison of the Yuzpe regime, danazol and mifepristone in oral post-coital contraception. The patient's latest episode occurred after he had failed to take his usual prophylactic dose of danazol (200 mg/day) during the previous 2 weeks. |
| Medical Dictionary |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content | Linking | Lookup box | Double-click lookup | Partner with us |
|---|